Related Experiment Videos
Colorectal cancer-associated nuclear antigen
P Szymczyk1, J Jakubik, W M Krajewska
1Department of Cytobiochemistry, University of Lódź, Poland.
Biochimica Et Biophysica Acta
|June 6, 2000
Summary
Researchers identified a novel p36 protein linked to colorectal cancer development. This protein was found in most tumor samples but not in healthy tissues, suggesting its role in large intestine tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Colorectal cancer (CRC) is a significant global health concern.
- Identifying specific biomarkers for early detection and understanding tumorigenesis is crucial.
Purpose of the Study:
- To identify and characterize novel nuclear proteins associated with colorectal cancer development.
- To investigate the expression patterns of a specific antigen, p36, in colorectal tumors.
Main Methods:
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting assays were employed.
- Polyclonal antiserum was raised against specific colorectal cancer nuclear polypeptides (35-40 kDa).
- Nuclear fractionation techniques were used to localize the antigen within cellular components.
Main Results:
- A p36 protein was identified, with its expression correlating with large intestine tumorigenesis.
- p36 antigen was detected in 81.8% of right-sided and 87.5% of left-sided colorectal tumors, but absent in control tissues.
- p36 was also identified in SW620 and HT29 colon tumor cell lines and concentrated in the internal nuclear matrix.
Conclusions:
- The p36 protein is a potential biomarker for colorectal cancer.
- Its presence in tumor tissues and localization within the nuclear matrix warrant further investigation into its role in tumorigenesis.